Abstract
We evaluated a family with a 16-month-old boy with cirrhosis and hepatocellular carcinoma and his 30-month-old brother with cirrhosis. After failing to identify a diagnosis after routine metabolic evaluation, we utilized a combination of RNA-Seq and whole exome sequencing to identify a novel homozygous p.Ser171Phe Transaldolase (TALDO1) variant in the proband, his brother with cirrhosis, as well as a clinically asymptomatic older 8-year-old brother. Metabolite analysis and enzymatic testing of TALDO1 demonstrated elevated ribitol, sedoheptitol, and sedoheptulose-7P, and lack of activity of TALDO1 in the three children homozygous for the p.Ser171Phe mutation. Our findings expand the phenotype of transaldolase deficiency to include early onset hepatocellular carcinoma in humans and demonstrate that, even within the same family, individuals with the same homozygous mutation demonstrate a wide range of phenotypes.
Competing interests: None declared
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Balasubramaniam S, Wamelink MM, Ngu LH et al (2011) Novel heterozygous mutations in TALDO1 gene causing transaldolase deficiency and early infantile liver failure. J Pediatr Gastroenterol Nutr 52(1):113–116
Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162(1):156–159
Chung WK, Shin M, Jaramillo TC et al (2009) Absence epilepsy in apathetic, a spontaneous mutant mouse lacking the h channel subunit, HCN2. Neurobiol Dis 33(3):499–508
Eyaid W, Al Harbi T, Anazi S et al (Jan 12 2013) Transaldolase deficiency: report of 12 new cases and further delineation of the phenotype. J Inherit Metab Dis (Epub ahead of print)
Fung CW, Siu S, Mak C, Poon G et al (2007) A rare cause of hepatosplenomegaly-Transaldolase deficiency. J Inherit Metab Dis 30(Suppl 1):62
Hanczko R, Fernandez DR, Doherty E et al (2009) Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine. J Clin Invest 119(6):1546–1557
Jansen G, Muskiet FA, Schierbeek H, Berger R, van der Slik W (1986) Capillary gas chromatographic profiling of urinary, plasma and erythrocyte sugars and polyols as their trimethylsilyl derivatives, preceded by a simple and rapid prepurification method. Clin Chim Acta 157(3):277–293
Li H, Handsaker B, Wysoker A et al (2009) The sequence alignment/Map format and SAMtools. Bioinformatics 25(16):2078–2079
Thorell S, Gergely P Jr, Banki K, Perl A, Schneider G (2000) The three-dimensional structure of human transaldolase. FEBS Lett 475(3):205–208
Trapnell C, Pachter L, Salzberg SL (2009) TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25(9):1105–1111
Tylki-Szymanska A, Stradomska TJ, Wamelink MM et al (2009) Transaldolase deficiency in two new patients with a relative mild phenotype. Mol Genet Metab 97(1):15–17
Valayannopoulos V, Verhoeven NM, Mention K et al (2006) Transaldolase deficiency: a new cause of hydrops fetalis and neonatal multi-organ disease. J Pediatr 149(5):713–717
Verhoeven NM, Huck JH, Roos B et al (2001) Transaldolase deficiency: liver cirrhosis associated with a new inborn error in the pentose phosphate pathway. Am J Hum Genet 68(5):1086–1092
Verhoeven NM, Wallot M, Huck JH et al (2005) A newborn with severe liver failure, cardiomyopathy and transaldolase deficiency. J Inherit Metab Dis 28(2):169–179
Wamelink MM, Smith DE, Jakobs C, Verhoeven NM (2005a) Analysis of polyols in urine by liquid chromatography-tandem mass spectrometry: a useful tool for recognition of inborn errors affecting polyol metabolism. J Inherit Metab Dis 28(6):951–963
Wamelink MM, Struys EA, Huck JH et al (2005b) Quantification of sugar phosphate intermediates of the pentose phosphate pathway by LC-MS/MS: application to two new inherited defects of metabolism. J Chromatogr B Analyt Technol Biomed Life Sci 823(1):18–25
Wamelink MM, Smith DE, Jansen EE, Verhoeven NM, Struys EA, Jakobs C (2007) Detection of transaldolase deficiency by quantification of novel seven-carbon chain carbohydrate biomarkers in urine. J Inherit Metab Dis 30(5):735–742
Wamelink MM, Struys EA, Jakobs C (2008a) The biochemistry, metabolism and inherited defects of the pentose phosphate pathway: a review. J Inherit Metab Dis 31(6):703–717
Wamelink MM, Struys EA, Salomons GS, Fowler D, Jakobs C, Clayton PT (2008b) Transaldolase deficiency in a two-year-old boy with cirrhosis. Mol Genet Metab 94(2):255–258
Wang Z, Gerstein M, Snyder M (2009) RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 10(1):57–63
Acknowledgments
Birthe Roos and Erwin Jansen are kindly acknowledged for their analytical contributions.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Communicated by: K. Michael Gibson
Appendices
One-Sentence Summary
We utilized a combination of RNA-Seq and whole exome sequencing to identify a novel homozygous p.Ser171Phe Transaldolase (TALDO1) mutation in a 16-month-old child to develop cirrhosis and hepatocellular carcinoma and biochemically confirmed that three affected siblings demonstrate a wide range of phenotypes from being asymptomatic to cirrhosis to hepatocellular carcinoma.
Conflict of Interest
Charles A. LeDuc, Elizabeth E. Crouch, Ashley Wilson, Jay Lefkowitch, Mirjam M.C. Wamelink, Cornelis Jakobs, Gajja S Salomons, Xiaoyun Sun, Yufeng Shen, and Wendy K. Chung declare that they have no conflict of interest.
Informed Consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study.
Details of the Contributions of Individual Authors
CAL and WKC wrote the manuscript with assistance from EEC, YS, MW, CJ, and GS. JL did the histological analysis. MW, CJ, and GS did the metabolic analysis. YS and XS did the alignment and variant calling. CAL and EEC tested and analyzed the variants. AW and WKC did the clinical workup on the patient. The study was designed by WKC.
Rights and permissions
Copyright information
© 2013 SSIEM and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
LeDuc, C.A. et al. (2013). Novel Association of Early Onset Hepatocellular Carcinoma with Transaldolase Deficiency. In: Zschocke, J., Gibson, K., Brown, G., Morava, E., Peters, V. (eds) JIMD Reports - Volume 12. JIMD Reports, vol 12. Springer, Cham. https://doi.org/10.1007/8904_2013_254
Download citation
DOI: https://doi.org/10.1007/8904_2013_254
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-03460-7
Online ISBN: 978-3-319-03461-4
eBook Packages: MedicineMedicine (R0)